Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,179 Million (Small Cap)
16.00
NA
0.00%
-0.83
1.42%
0.23
Revenue and Profits:
Net Sales:
106 Million
(Quarterly Results - Jun 2025)
Net Profit:
25 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.61%
0%
1.61%
6 Months
5.86%
0%
5.86%
1 Year
2.72%
0%
2.72%
2 Years
-2.68%
0%
-2.68%
3 Years
-44.64%
0%
-44.64%
4 Years
-37.42%
0%
-37.42%
5 Years
0%
0%
0.0%
Assure Tech (Hangzhou) Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-58.26%
EBIT Growth (5y)
-123.68%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
0.10
Tax Ratio
8.65%
Dividend Payout Ratio
79.30%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.62%
ROE (avg)
18.94%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
0.23
EV to EBIT
64.33
EV to EBITDA
-306.19
EV to Capital Employed
-3.48
EV to Sales
-6.09
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
1.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
106.10
113.30
-6.35%
Operating Profit (PBDIT) excl Other Income
-0.20
10.90
-101.83%
Interest
0.00
0.00
Exceptional Items
11.10
11.30
-1.77%
Consolidate Net Profit
25.00
34.20
-26.90%
Operating Profit Margin (Excl OI)
-145.40%
-37.90%
-10.75%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -6.35% vs -15.89% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -26.90% vs -39.47% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
534.00
494.80
7.92%
Operating Profit (PBDIT) excl Other Income
38.30
52.90
-27.60%
Interest
1.20
1.70
-29.41%
Exceptional Items
60.80
-49.60
222.58%
Consolidate Net Profit
192.20
141.00
36.31%
Operating Profit Margin (Excl OI)
-37.50%
-38.70%
0.12%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 7.92% vs -91.91% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 36.31% vs -95.37% in Dec 2023
About Assure Tech (Hangzhou) Co., Ltd. 
Assure Tech (Hangzhou) Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






